213 related articles for article (PubMed ID: 11606489)
1. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret.
Van Sickle MD; Oland LD; Ho W; Hillard CJ; Mackie K; Davison JS; Sharkey KA
Gastroenterology; 2001 Oct; 121(4):767-74. PubMed ID: 11606489
[TBL] [Abstract][Full Text] [Related]
2. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
3. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
Van Sickle MD; Oland LD; Mackie K; Davison JS; Sharkey KA
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G566-76. PubMed ID: 12791597
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations.
Abalo R; Rivera AJ; Vera G; Suardíaz M; Martín MI
Neurosci Lett; 2005 Jul 22-29; 383(1-2):176-81. PubMed ID: 15936532
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets.
Simoneau II; Hamza MS; Mata HP; Siegel EM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2001 May; 94(5):882-7. PubMed ID: 11388542
[TBL] [Abstract][Full Text] [Related]
6. Depolarization-induced release of endocannabinoids by murine dorsal motor nucleus of the vagus nerve neurons differentially regulates inhibitory and excitatory neurotransmission.
Roux J; Wanaverbecq N; Jean A; Lebrun B; Trouslard J
Neuropharmacology; 2009 Jun; 56(8):1106-15. PubMed ID: 19332082
[TBL] [Abstract][Full Text] [Related]
7. Δ
Darmani NA; Belkacemi L; Zhong W
Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
[TBL] [Abstract][Full Text] [Related]
8. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
9. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
Darmani NA
J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
[TBL] [Abstract][Full Text] [Related]
10. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
11. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
12. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
Hodges LC; Reggio PH; Green K
Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
[TBL] [Abstract][Full Text] [Related]
16. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
Bereiter DA; Bereiter DF; Hirata H
Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
[TBL] [Abstract][Full Text] [Related]
17. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
Darmani NA
Eur J Pharmacol; 2001 Oct; 430(1):49-58. PubMed ID: 11698062
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs.
Harada N; Nemoto K; Okamura T; Ninomiya N; Suzuki H; Yamamoto Y
J Nippon Med Sch; 2005 Feb; 72(1):43-51. PubMed ID: 15834207
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings.
Yazulla S; Studholme KM; McIntosh HH; Fan SF
Vis Neurosci; 2000; 17(3):391-401. PubMed ID: 10910107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
